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Neurogenesis, a process of generating functional neurons from neural precursors, occurs
throughout life in restricted brain regions such as the subventricular zone (SVZ). During
this process, newly generated neurons migrate along the rostral migratory stream to
the olfactory bulb to replace granule cells and periglomerular neurons. This neuronal
migration is pivotal not only for neuronal plasticity but also for adapted olfactory
based behaviors. Perturbation of this highly controlled system by exogenous chemicals
has been associated with neurodevelopmental disorders. We reported recently that
perinatal exposure to low dose herbicide glufosinate ammonium (GLA), leads to long
lasting behavioral defects reminiscent of Autism Spectrum Disorder-like phenotype in
the offspring (Laugeray et al., 2014). Herein, we demonstrate that perinatal exposure
to low dose GLA induces alterations in neuroblast proliferation within the SVZ and
abnormal migration from the SVZ to the olfactory bulbs. These disturbances are not
only concomitant to changes in cell morphology, proliferation and apoptosis, but are
also associated with transcriptomic changes. Therefore, we demonstrate for the first
time that perinatal exposure to low dose GLA alters SVZ neurogenesis. Jointly with our
previous work, the present results provide new evidence on the link between molecular
and cellular consequences of early life exposure to the herbicide GLA and the onset of
ASD-like phenotype later in life.
Keywords: glufosinate ammonium, pesticide, neuroblasts migration, SVZ, neuro-development, cytoskeleton,
Autism Spectrum Disorder
INTRODUCTION
Production of neurons is an active ongoing process with 10,000 to 30,000 neurons being produced
daily in rodents (Lledo et al., 2006). While the molecular mechanisms involved are not fully
understood, the persistence of neurogenesis in adult subventricular zone (SVZ) is currently well-
established (Ghashghaei et al., 2007). The SVZ newly generated neurons migrate along the rostral
migratory stream (RMS) to the olfactory bulb (OB) where they will be used to replace granule cells
Herzine et al. GLA Impairs Neurogenesis and Neuroblast Migration
and periglomerular neurons (Lois and Alvarez-Buylla,
1994). RMS is characterized by neuroblasts organized into
chains continually migrating through an astrocytic tube-like
structure called the glial tube (Sun et al., 2010). This ongoing
process is tightly regulated through multiple secretory signals
including mitogenic factors (i.e., EGF, Notch) within the SVZ,
repulsive factors along the RMS (i.e., Slit, Ephrin, Netrin), and
chemoattractive factors (i.e., Reelin, Neuregulin) within the
OB (Coskun and Luskin, 2002; Whitman and Greer, 2009).
In terms of overall brain function, neuroblast migration is of
particular relevance to olfactory-based neuronal plasticity and for
consequent adapted behavior such as fine-odor discrimination
(Gheusi, 2000).
As for all tightly controlled system, any disturbances could
dramatically change the outcome of neuroblast generation or
migration (Khodosevich et al., 2009; Sun et al., 2010; Young
et al., 2011), and so, would likely lead to neurodevelopmental
disorders. In line with this, Autism Spectrum Disorders (ASD)
are thought to be associated with alterations in neonatal
neurogenesis in the SVZ (Kotagiri et al., 2014). Indeed, it
was shown that neurobehavioral defects concomitant to cellular
SVZ abnormalities were induced by perinatal exposure to
methotrexate (Seigers et al., 2015; Hirako et al., 2016).
Many mediators are involved in the homeostasis of SVZ
neurogenesis and neuroblast migration but the neurotransmitter
glutamate has been shown to be of particular importance in
controlling these processes (Di Giorgi-Gerevini et al., 2005;
Platel et al., 2007, 2010). The herbicide Glufosinate ammonium
(GLA), is the ammonium salt of phosphinothricin (D,L-
homoalanin-4-[methyl] phosphinate), an aminoacid structurally
related to glutamate and as such is likely to interfere with
glutamate signaling. Acute exposure to GLA causes disturbances
of the glutamate homeostasis, memory impairments, brain
structural modifications, and astrogliosis (Nakaki et al., 2000;
Calas et al., 2008, 2016; Meme et al., 2009). Furthermore, we
recently showed that GLA has pervasive and harmful effects
when administered during the highly sensitive pre- and post-
natal periods of brain development (Laugeray et al., 2014).
Neurobehavioral tests revealed significant effects of maternal
exposure to GLA on offspring’s early reflex development,
mother-pup communication and affiliative behaviors later in
life. We could also show that perinatal exposure to GLA
strongly affected offspring’s ability to prefer social olfactory cues
over non-social ones. This latter alteration led us to assume
that the birth/renewal of SVZ—olfactory bulbs neurons (the
main system underlying olfactory-based behaviors in rodents)
may be compromised by the herbicide. Interestingly, the
expression of two genes involved in the regulation of neuroblast
proliferation, migration and apoptosis during brain development
(Li et al., 2002; Wang et al., 2004), Pten and Peg3, were
dysregulated in GLA-exposed offspring’s brain (Laugeray et al.,
2014).
Based on these behavioral and gene expression disturbances,
we were interested in the present report in investigating
whether GLA-induced-neuropathological conditions may be due
to neurogenesis defects and alterations in neuroblast homeostasis
by using complementary in vivo and ex-vivo approaches.
MATERIALS AND METHODS
Animals and Treatments
Seven-week-old female C57Bl/6 mice were purchased from
Janvier (Le Genest St Isle, France). All mice were bred and
maintained on a 12-h light/dark cycle (lights on from 7:00 a.m.
to 7:00 p.m.) with food and water ad libitum in a temperature
controlled (21± 1◦C) room in the animal resource facility. After
an acclimatization period of 2 weeks, female mice were mated
with male C57Bl6 mice also obtained from Janvier (Le Genest St
Isle, France) during 5–6 days. Pregnant mice were then isolated
and divided in three experimental groups treated intranasally
with either GLA (1 or 0.2mg/kg; PESTANAL R©, analytical
standard from Sigma–Aldrich) or saline solution (NaCl 0.9%; 10
µl/30 g mouse) as control. These two doses were not only chosen
as they were shown to induce bio-behavioral abnormalities in our
previous study (Laugeray et al., 2014) but also because they are
∼5 to 25 times lower than the EPA approved dose (EPA, 2012).
Intranasal exposure was not only chosen as a realistic model
of human exposure to volatile toxicants through inhalation but
also as it is known that such substances may reach the body
via the systemic route without liver interaction (Benson et al.,
1999; Amuzie et al., 2008). Therefore, many volatile substances
may have deleterious consequences, especially in situation of
long-lasting or recurrent exposure to low dose pesticides. Dams
were treated during pregnancy and lactation periods three times
a week from embryonic day 7-10 (E7-10) to postnatal day 15
(PND15) (Figure 1). Control animals received a comparable
dose of 0.9% saline vehicle. Offspring were maintained in
same-sex, litter-mate housed cages with ad libitum access to
food and water. All aspects of animal care and experimentation
were in accordance with the European Communities Council
directive (2010/63/EU). The Ethics committee approved
all animal care and use for this study (Approval C45-
234-6).
General Procedure
General procedure is shown in Figure 1. From E10 to
PND15, we performed preweaning tests to check developmental
consequences of perinatal exposure to GLA. With this aim,
we investigated neuroblast migration and proliferation by
Bromodeoxyuridine (BrdU) labeling in vivo from PND5 to
PND15 and ex vivo on Matrigel at PND5. Western Blot,
Apoptag R©, immunochemistry and transcriptomic arrays were
performed on PND15 mice brain.
Cultures of SVZ Explants
Brains from 5 day-old C57bl/6 perinatal treated mice (GLA0.2 or
GLA1) or control (CTL) were positioned in ice-cold Leibovitz’s
L-15 medium (GIBCO). The SVZ from the lateral wall was
dissected and sectioned using a vibratome (Leica VT1200S) into
pieces 50–300 µm in diameter. The explants were mixed with
BD Matrigel
TM
Matrix (BD Biosciences) and allowed to solidify
in a culture dish (GIBCO). The gel containing the explants was
overlaid with 500µl of Neurobasal medium (GIBCO) containing
10% SVF (Hyclon), B-27 supplement (GIBCO), 0.5 mM L-
glutamine (GIBCO), and penicillin–streptomycin antibiotics
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FIGURE 1 | Study experimental design. After 2 weeks acclimation female mice were paired with male mice for 5–6 days to mate. Pregnant mice were treated
intranasally with either GLA (0.2 or 1 mg/kg) or saline solution. Dams were treated three times a week from embryonic day 10 (E10) to postnatal day 15 (PND15). At
PND5, a group of pups were injected with 100 mg/kg BrdU; 2 h (T0+2 h), 48 h (T0+2 D) or 10 days later (T0+10 D), they were euthanized, and the brains processed
for immunohistochemistry. Other pups were euthanized at PND5 and brains processed for culture of SVZ explant, or at PND15 and brains processed for
transcriptomic arrays.
(GIBCO). Cultures were maintained 3 days in vitro (3DIV) in a
humidified, 5% CO2, 37◦C incubator (RS Biotech).
BrdU Labeling
Bromodeoxyuridine (BrdU, Sigma), commonly used as a mitotic
marker, can inform on neuroblast migration. It is well-described
that within the RMS, migrating neuroblasts divide only in the
initial portion of the RMS, so BrdU+ cells detected in rostral
regions must have proliferated in caudal regions or SVZ, making
BrdU labeling a strategy to trace cell migration from the SVZ to
the OB. This approach allowed us to evaluate the proliferation
and the migration of neuroblasts in the RMS. This kind of
analysis had the advantage of looking at the entire population of
cells being generated. Thus, cells labeled, although not directly
identified, are likely to be primarily precursors of olfactory bulb
neurons (Ono et al., 1994). Migration of cells from the SVZ to the
OB involves several processes: the initial decision to exit the SVZ,
the migration of cell along the RMS, and the radial migration of
individual cells from the end of the RMS into the glomerular layer
of the OB (Peretto et al., 1999).
To evaluate the proliferative and migrating abilities of
neuroblasts between the SVZ and the OB, BrdU (100 mg/kg;
Figure 1) was administered subcutaneous to PND5 GLA-
exposed, as well as controls pups. After 2 h, 2 days or 10 days,
brains were harvested, fixed, cryoprotected (see below for details)
and 14 µm sections were processed (obtained from a cryostat;
Leica) using standard immunofluorescence techniques with
BrdU monoclonal antibody Alexa Fluor 488 at 1:1000 dilution,
counterstained with DAPI (10 µg/ml, Sigma) and coverslipped
with fluoromount. Because of the impossibility to determine the
number of nuclei within the RMS and the neuroepithelium (NE),
we measured integrated intensity (RawIntDen) of BrdU-labeled
cells located in the rostral SVZ, the NE and glomerular layer (Glo)
with ImageJ R© software (NIH) on raw 32 bits imagery according
to ImageJ recommendation (Burgess et al., 2010; McCloy et al.,
2014) (Supplementary Figure 2). At least 10 sections per animal
and per structure were examined.
Immunohistochemistry (IHC)
Brains from PND5, 7, and 15 were fixed by immersion in 4%
paraformaldehyde (PFA) in 100 mM phosphate buffer, pH
7.4, for 72 h at 4◦C and cryoprotected in Tris-buffered saline
(TBS) (50 mM Tris-Hcl, pH7.5, 150 mM NaCl) containing 30%
sucrose before embedding in Optimum Cutting Temperature
(OCT) compound (Sakura Finetek) and frozen in isopentane
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cooled up to −50◦C. Histological coronal sections were
mounted onto superfrost+ slides (VWR). Antigen retrieval
was performed by incubating the sections in 10 mM sodium
citrate solution (pH 9.0) for 30 min in an oven (80◦C) (Jiao
et al., 1999) and pre-blocked for IHC for 30 min to 1 h in
TBS with 0.3% Triton X-100, 10% normal goat serum and
1% bovine serum albumine (BSA). Sections were incubated
overnight at 4◦C with the primary antibodies. The following
antibodies were used: rabbit polyclonal (pAb) anti-DCX (1:500;
Abcam, ab77450), rat monoclonal pAb anti-BrdU (1:500;
Abcam, ab6326), mouse monoclonal (mAb) anti-Reelin (1:500;
Abcam, ab18570) and species-specific secondary antibodies
(Abcam). Sections were counterstained with DAPI (10 µg/ml,
Sigma), mounted in Fluoromount-G (SouthernBiotech)
and images were captured using a fluorescence
microscope (DM6000B; Leica Microsystems) powered by
Metamorph software. Measurements were performed with
Image J.
In the case of concomitant labeling of BrdU, selected sections
from BrdU labeled brains was initiated by the pre-treatment of
sections with 10mM sodium citrate solution (pH 9.0) for 30 min
in an oven (80◦C). Next, 1NHCl for 10min at 4◦C, then 2NHCL
for 30min at 37◦C.
Immunocytochemistry
Immunological characterization of cells in chains was performed
directly in culture dishes. Samples were fixed with 4% PFA
solution in TBS (pH 7.4) for 10 min at room temperature
and blocked for 20 min in TBS containing 10% normal goat
serum, 1% BSA, and 0.2% Triton X-100. Incubation was
with primary monoclonal antibodies (rabbit IgG anti-DCX
1:500 dilution; Abcam), carried out 1 h in humidified box at
room temperature (RT). The samples were washed with TBS
and incubated with species-specific secondary antibodies (anti-
IgG Alexa488 Abcam) for 30 min at RT. Samples washed
in TBS and counterstained with DAPI (10µg/ml, Sigma),
mounted in Fluoromount-G (SouthernBiotech) and examined
with a fluorescence microscope. Images were captured using a
Leica DM6000B microscope powered by Metamorph software.
Measurements were performed with Image J.
TUNEL Assay
TUNEL assays were conducted with an ApopTag R© Red
In Situ Apoptosis Detection Kit (S7165, EMD Millipore)
following the indicated protocol. Briefly, sections were
treated as indicated above, fixed in 1% PFA, washed in TBS
three times, incubated in equilibration buffer (potassium
cacodylate; provided in the kit) for 10 min and incubated
with terminal deoxynucleotidyl transferase for 60 min at
37◦C. After 10 min in stop buffer (provided in the kit),
sections were incubated with anti-digoxigenin conjugate
overnight at 4◦C. After washing in TBS, sections counterstained
with DAPI (10µg/ml, Sigma), mounted in Fluoromount-G
(SouthernBiotech) and examined with a fluorescence microscope
(Leica).
Microscopy and Imaging
A conventional fluorescence microscope (Leica DM6000B) was
used for the rough inspection of stained sections. Images
from stained sections were captured with a digital microscope
camera (Leica DFC310 FX) and Metamorph software. Selected
fluorescently labeled tissues were analyzed with ImageJ software.
RNA Extraction
RNA extraction from PND15 brain murine tissues was carried
out using Trizol reagent (Invitrogen, Carlsbad, CA) following
the manufacturer’s instructions. Quantity and quality of the
total RNA were controlled by Nanodrop spectrophotometer
(Nanodrop, Wilmington, DE) and Agilent Bioanalyser (Agilent
technologies, Palo Alto, CA) in accordance with manufacturer’s
instructions. Samples A260/A280 absorbance ratio was greater
than 1.8 and 28S/18S rRNA ratio greater than 1.5.
Affymetrix Mice Exon 1.0 ST Array 1.0 and
Micro-Arrays Analyses
Gene expression was tested by the Affymetrix Mice Exon
1.0 ST Array (Affymetrix, Santa Clara, CA). A total of 2 µg
of RNA from each brain samples was labeled with reagents
from Affymetrix according to manufacturers’ instructions.
Hybridization cocktails containing 5–5.5 µg of fragmented, end-
labeled single-stranded cDNA were prepared and hybridized
to GeneChip Mouse Exon 1.0 ST arrays. Arrays were washed,
stained and scanned on the Affymetrix Fluidics Station
and G7 Affymetrix high-resolution scanner (GCOS 1.3).
Affymetrix Expression Console Software
TM
(version 1.0) was
used to perform quality assessment. Raw signals were then
transformed into “.CEL” files in GCOS software (Affymetrix,
Santa Clara, CA). Probe data were generated using the Robust
Multi-chip Average with GC-content Background Correction
(GCRMA, http://www.bioconductor.org) in Genespring
7 software (Silicon Genetics, Redwood City, CA). This
involves background correction, quantile normalization, and
summarization of the probe-set values into gene-level expression
measurements.
In this study we focus our interest on genes involved in
the overall cytoskeleton structure, biogenesis, organization or
regulation. Cytoskeleton gene list was obtained from the database
GSEA (http://software.broadinstitute.org/gsea/index.jsp), and
injected in Genespring 7 to investigate gene deregulation in our
experimental groups (GLA0.2 and GLA1). Thus, differentially
regulated cytoskeleton genes were determined using a one-way
ANOVA analysis and a Benjamini Hochberg False Discovery Rate
(FDR) (<0.05) method for multiple comparison corrections.
This statistic protocol was classically used in the literature for
analyzing microarrays expression data (Bittel et al., 2007; Perche
et al., 2013). Only those genes whose expression changed at least
1.2-fold from the baseline value were selected for downstream
analysis. This filter helped maximing the number of genes. PCR
quantitative was used to validate the expression arrays, through
validation of 45 genes.
Genes that met statistical criteria were analyzed using the
DAVID (Database for Annotation, Visualization and Integrated
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Discovery, Bioinformatics Resources 6.7) for cytoskeleton KEGG
pathway visualization.
Statistical Analysis
All data, other than micro array analyses, were analyzed by
using parametric procedures: when more than two groups were
involved, one-way ANOVA was applied. When appropriate,
Dunn’s multiple comparison test was performed as post-hoc in
order to control the false directory rate. Significance was set at
P < 0.05.
Concerning microarrays, differentially regulated cytoskeleton
genes were determined using a one-way ANOVA analysis and
a Benjamini Hochberg False Discovery Rate (FDR) (<0.05)
method for multiple comparison corrections.
RESULTS
Effect of GLA Exposure on Subventricular
Zone Structure and Neuroblast Chain
Migration
With the aim to investigate the effect of GLA exposure on the
SVZ, we first carried out morphological measurements of SVZ
thickness in PND15 CTL and GLA-exposed pups (Figure 2A).
GLA0.2-exposed offspring displayed a 46.9% increased SVZ
thickness compared to control mice (Figure 2B). This increase
was associated with an increased number of DCX-positive
neuroblasts in the SVZ (Figure 2C). Interestingly no difference
in SVZ thickness was observed in GLA1-exposed offspring
(Figures 2B,C). However, we observed that GLA1 treatment
promoted ectopic migration of neuroblasts to the surrounding
brain regions as, DCX+ cells were observed in the caudate
putamen (Cpu). Then we characterized the effect of GLA ex
vivo by using SVZ explants and verified whether neuroblast
morphology and/or migration were altered. CTL explants were
made of individual long chains of DCX+ cells, extending from
the SVZ while explants collected from GLA-treated pups were
quite different as chain morphology was completely altered
(Figure 3). Indeed, SVZ explants coming from GLA0.2 pups
displayed chains with a compacted morphology compared to
CTL. In explants from GLA1-exposed pups, chains of neuroblast
were similar to those of CTL explants in terms of thickness but
seemed to be cell-enriched. We quantified this phenomenon by
measuring the number of nucleus per chain length. We clearly
observed an increase in cell number in explants coming from
GLA-exposed pups (Figure 3C). Moreover, in explants from
GLA1 pups, migrating cells displayed abnormalmorphology with
(1) extension and branching of the growth cone, (2) abnormally
long dendrites, and (3) overall loosing of their bipolarity
(Supplementary Figure 3). These data were corroborated by
the measurement of the number of chains and the number of
individual cells per surface unit. Indeed, there was a significant
decrease of the number of chains/mm2 for GLA0.2 and GLA1
explants compared to CTL. Further, there was a significant
increase in cells migrating individually in the GLA0.2 and GLA1
explants compared to CTL. The effect seemed to be more
pronounced at the lowest dose of GLA (Figures 3D,E).
Perinatal GLA Exposure Impairs Cell
Proliferation in the Sub-ventricular Zone
and Migration toward the Olfactory Bulb
To verify whether GLA exposure was responsible for changes in
the temporal dynamics of neuroblast migration from the SVZ to
the OB, BrdU+ cells were determined in the rostral region of
the SVZ, the NE and the Glo of the olfactory bulbs at several
timepoints post-BrdU injection: 2 h (T0+2 h), 2 days (T0+2
D) or 10 days (T0+10 D) after BrdU injection. Actually, each
point gave us information on the location of BrdU-incorporated
migrating cells at 5, 7, and 15 days post-natal.
Consistent with previous reports (Luo et al., 2006), BrdU+
nuclei were found throughout the lateral portions of the SVZ
(data not shown) at T0+2 h (PND5). Quantitative analysis of
BrdU labeling in the SVZ revealed a significant decrease in cell
proliferation in GLA0.2-exposed mice compared to CTL while
no effect was observed in GLA1-exposed mice (Figure 4A). In
the NE and Glo, the intensity of BrdU+ cells was similar in the
three groups. At T0+2 D (PND7), in CTL group, about half
of the BrdU labeled cells reached the NE while a few remained
at the rostral SVZ. Interestingly, a third of the BrdU-labeled
SVZ level observed at T0+2 h remained labeled at T0+10 D,
suggesting that they incorporated BrdU in or near to their
final mitosis. At that time, the SVZ-NE-Glo level of BrdU+
dramatically changed in CTL animals (Figure 4) reflecting the
migration of cells toward and into the olfactory bulb. In GLA0.2-
exposed mice, this process appeared to be delayed. Indeed, BrdU
levels at T0+2 D remained similar to those found in the SVZ
at T0+2 h for GLA0.2 exposed mice. This finding suggested
that cells could not leave the SVZ with an adapted timing to
reach their final location, the OB. The fact that about two-
thirds of the BrdU+ cells was located in the SVZ at T0+10
D not only strengthened this hypothesis (Figure 4B1) but also
indicated that, in GLA0.2-exposed-pups, most of the migrating
cells stayed close to their final division location for at least
7–10 days. In GLA1-exposed pups, the temporal dynamics of
neuroblast migration was differently altered as, like in CTL
pups, BrdU-labeling was significantly decreased in the SVZ at
T0+2 D. This result indicated that cells were able to leave
the SVZ to reach the OB. However, there was no significant
increase of BrdU+ cells in NE or OB at T0+2 D contrary
to what we observed in the CTL group (Figures 4B1,B2). To
verify whether apoptosis may explain GLA-induced changes in
neuroblast migration dynamics, we quantified apoptotic cells
within the SVZ at PND15 and we observed a significant
increase of apoptotic cells at the highest dose of GLA while
no change was noticed at the lowest one (Figures 5A,B). Such
a phenomenon suggested that apoptotic processes might be
involved in GLA1-induced migration defects, and subsequently
explain the decreased arrival of BrdU+ cells in NE at T0+2 D
(Figures 5A,B), while other mechanisms might be at work in
GLA0.2-exposed pups.
At T0+10 D, we observed a drastic decrease of BrdU+
cells in NE and Glo in CTL animals (Figures 4B1,B2). Such a
phenomenon is normal as many migrating cells die by apoptosis
while only a small percentage of these cells reach the OB and
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FIGURE 2 | Effect of perinatal glufosinate ammonium exposure on neuroblast migration along the SVZ. (A) Diagram of a coronal section at SVZ level (green
area). Coronal sections (red square) were stained with DCX (doublecortin; nearly exclusive expression in neuroblasts; green staining) and counterstained with DAPI
(nuclear blue staining). Three measurements of thickness were carried for each SVZ (2 SVZ for each coronal section). Three coronal sections were analyzed per animal
(Bregma 1.145; 0.745; 0.245); the mean of all values represents one mice. (B) The SVZ thickness of GLA0.2 exposed mice (n = 5) was significantly increased
compared to CTL mice (n = 5). No difference was found in GLA1 exposed mice (n = 6). (C) Sections from GLA0.2 mice at PND15 display a more extensive SVZ
thickness than CTL. SVZ thickness from GLA1 mice was similar to CTL but with ectopic migration of neuroblasts outside the SVZ (red arrows). Scale bar 100µm.
Each value represents the mean ± SEM (***p < 0.001). lv, lateral ventricle; Cpu, Caudate putamen.
integrates local circuits (Khodosevich et al., 2009). In GLA0.2-
exposed mice, BrdU+ cells continued to increase at T0+10
D in the OB, while in GLA1-exposed pups, the number of
BrdU+ cells remained unchanged (Figure 4B2). Concomitantly,
apoptosis analysis within the OB revealed a clear decrease of
apoptotic cell number in the granular layer in both GLA0.2 and
GLA1-exposed pups compared to CTL even if the latter group
was minor affected. No changes were observed in NE and Glo
(Figures 5C,D).
Anatomical Alterations of Mitral Layer
Structure after GLA Exposure
In control mice, reelin immunohistological staining showed two
distinct staining regions clearly expressing reelin in the OB—the
glomerular (Glo) and mitral cell layers (MCL) (Figure 6). Reelin
expression outlined the glomeruli, and was found at high levels in
the MCL. In GLA-exposed mice, irrespective of the dose, mitral
cells appeared disorganized and the MCL slightly expanded
compared to CTL mice (arrows in Figure 6), suggesting defects
of neuronal lamination (Supplementary Figure 1). The other
layers appeared undisturbed. In normal OB, the mitral cell bodies
were located directly above the Granular cell layer (GrL) and
were oriented radially with their primary dendrites projected
directly toward the Glo. As shown in Figure 6, GLA-exposed
mice displayed several differences from this normal organization:
mitral cell bodies were not located immediately above the GrL
and were orientated radially. Furthermore, immunohistology
showed an increase of reelin+ cell number both after GLA0.2
and GLA1 perinatal exposure. In addition, analysis of whole
brain transcriptomic data highlighted that GLA1-exposed group
showed∼40% lower reelin gene expression compared to CTL.
Alteration of Cytoskeleton Regulation after
GLA Exposure
Since based on our histological analysis showing that GLA
exposure altered neuroblast migration and proliferation as well
as Pten expression (Laugeray et al., 2014), we decided to explore
cytoskeleton gene expression by transcriptomic.
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FIGURE 3 | Ex vivo culture of SVZ explant from perinatal GLA exposed mice. Culture on Matrigel of explants from the SVZ of brains from 5 day-old pups
treated perinatal with GLA0.2 (n = 11), GLA1 (n = 7) or control (CTL, n = 10) was performed for 3 days. We analyzed 6 to 10 explants per animal; the mean of all
values represent one mice. (A) The top panel shows a diagram of a coronal section at the SVZ (green area) and the explants were micro-dissected in the party
designated by the red square. The photograph on the right of this panel was obtained with an inverted microscope of culture at 3 day in vitro. The morphological
appearance of neuroblasts and formed chains were investigated by DCX immunocytology to mark neuroblasts (green) and nuclei with DAPI (blue) (B). The results
show classical bipolar spindle-shaped cells in contact with each other in CTL. Unlike GLA0.2 GLA1 show extensions and ramifications of the growth cone, a loss of
bipolarity and abnormal appearance and compact chains. The number of cells per unit distance was measured in formed chains and show a significant increase in this
number in GLA0.2 highlighting aggregation (C). Number of chains formed (D) or individual cells (E) were counted. The number of chains formed in explants exposed
mice to GLA0.2 and GLA1 is significantly lower compared to the CTL. Therefore, the number of isolated free cells is significantly higher in exposed mice. These results
show the difficulty of neuroblasts to migrate and form chains. Each value is represented by the mean ± SEM (*p < 0.05; ***p < 0.001). Scale bar 100µm.
For this purpose, we focused on gene expression levels of
cytoskeleton pathway and selected from GSEA database a list
of 494 genes involved in cytoskeleton structure, biogenesis,
organization, or regulation. Among this list, one-way ANOVA
followed by Benjamini Hochberg multiple testing correction
demonstrated that 371 genes were significantly deregulated by
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FIGURE 4 | BrdU labeling reveals GLA-induced alterations of neuroblast migration in vivo. The top panel shows a diagram of coronal sections at the SVZ
and OB, the ventricular walls are colored in green. The BrdU labeling intensity was measured in mouse brain coronal sections of CTL (n = 3), GLA0.2 (n = 3) and
GLA1 (n = 3) previously injected with BrdU at PND5 and sacrificed after 2 h (T0+2 h) or 2 days (T0+2 D) or 10 days (T0+10 D). The density of BrdU is measured
around the SVZ (A) or around the OB (B) in the neuro-epithelium (NE) (B1) and in the glomerular layer (Glo) (B2). At T0+2 h, the BrdU density represents the rate of
(Continued)
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FIGURE 4 | Continued
cell proliferation. The results show a decrease of proliferation only in GLA0.2 animals at the SVZ. No proliferation differences were detected at the OB. Measurements
performed at 48 h after BrdU injection (T0+2 D) and compared to those performed at T0+2 h indicate cell movements between the SVZ to the OB in CTL animals. At
the SVZ, a decrease of intensity is noted in CTL and GLA1 but not in GLA0.2 exposed animals. In the same way, there is an increase of the BrdU density only in CTL
OB. We note here that neuroblasts had difficulties to reach the OB in exposed animals to GLA. At T0+10 D, the fluorescence density of BrdU is lowest and similar in
all groups in the SVZ. However, at the OB, the fluorescence density of BrdU is greater in GLA0.2 and GLA1 exposed animals than in CTL. Control, white bar chart,
GLA0.2, gray bar chart; GLA1, black bar chart. Each value is represented by the mean ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001).
FIGURE 5 | Apoptotic cells labeling in SVZ and in the olfactory bulb. Apoptag® immunostaining of coronal sections of CTL (n = 3), GLA0.2 (n = 3) or GLA1 (n
= 3) in the SVZ (A) and in the OB (C) showing a dose effect of GLA in the increase of apoptotic cells in the SVZ of exposed mice (B). Unlike to SVZ, we show a
significant decrease of the number of apoptotic cells in the granular layer (Grl) of exposed mice (D). No difference was found in neuro-epithelium (NE) and in glomerular
layer (Glo). Each value represents the mean ± SEM (*p < 0.05, ***p < 0.001). Scale bar 100 µm.
GLA parental exposure. Among the 371 genes, we showed
that 122 genes were deregulated with at least 1.2-fold change
(FC1.2) in GLA0.2 and/or GLA1-exposed pups compared to
CTL (Table 1). Interestingly, 60 genes (10 Up, 50 Down)
were deregulated in GLA0.2-exposed pups whereas 73 genes
(37 Up, 36 Down) were affected in GLA1-exposed pups.
Only 11 genes, involved in actin cytoskeleton regulation
(KEGG pathway, DAVID, Bioinformatics Resources 6.7), were
commonly deregulated by both GLA perinatal treatments
(Table 1–lines in gray, and Figure 7). However, the deregulation
way (up or down-regulated) of these 11 genes were dependent
of GLA dose exposure. Indeed, in GLA0.2-exposed pups, 10 out
of 11 genes were down-regulated (Table 1, lines in gray) whereas
these same genes were up-regulated in GLA1-exposed pups. Only
one gene, Fscn1, was down-regulated in both conditions.
DISCUSSION
Although, it is nowwell-known that GLA is structurally related to
glutamate and clearly neurotoxic, its putative aversive effects on
neuroblast homeostasis (for which glutamate is of crucial value)
remained unexplored. Our recent study suggested that behavioral
alterations induced by perinatal exposure to GLA could be related
to neurogenesis disturbances due to altered brain expression of
relevant genes, like Pten, well-known to be importantly involved
in this process (Laugeray et al., 2014). Herein, we tested this
hypothesis thanks to both in vivo and ex vivo analyses.
SVZ as a Potential Open Window to GLA
Neurotoxicity
It is now well-established that the neurotransmitters GABA and
glutamate are of crucial importance during neuronal migration
from the SVZ to the OB and, as such, are likely to contribute to
the pathogenesis of neuronal migration disorders (Platel et al.,
2010). Here, we assumed that GLA, as an analog of glutamate, can
affect cell proliferation and neuroblast migration by interfering
with glutamate signaling, and thus with SVZ functions. In
agreement with this hypothesis glutamate homeostasis is known
to be importantly involved in RMS migration processes (Platel
et al., 2008). However further experiments are needed to support
this statement. We were able to show that exposure to low
dose GLA (GLA0.2) led to neuroblast accumulation in the
SVZ in vivo at PDN15. Such an alteration has already been
reported in some ASD patients (Wegiel et al., 2010). Together
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with our data, these findings strengthen our hypothesis of a
link between GLA exposure, abnormal neurogenesis in the
SVZ and ASD. Interestingly, at the highest dose, GLA did not
affect SVZ thickness but, rather, led to ectopic migration of
neuroblasts outside the SVZ. These data suggested that the
SVZ, lining the walls of the lateral ventricles, is sensitive to
exogenous toxicants, and subsequently may constitute the real
“window of the brain” as proposed by many authors (Gross
and Weindl, 1987; Moyse et al., 2006; Joly et al., 2007; Lin
et al., 2015). Such an assumption is reinforced by a recent
study showing that perinatal exposure to another environmental
toxicant, methotrexate, also led to SVZ alterations (Hirako et al.,
2016). These aversive effects of exogenous compounds on the
SVZ could be inherent to its intrinsic structure characterized by
permeable fenestrated capillaries and thus a lack of endothelial
blood–brain-barrier (BBB) (Johnson and Gross, 1993; Tavazoie
et al., 2008). Consequently, the SVZ stem cell niche is in the front
line to respond to systemic xenobiotics and is thus likely to be
extremely sensitive to environmental toxicants.
Impaired Proliferation, Migration, and
Apoptotic Processes after Perinatal
Exposure to GLA
Activation of glutamate receptors causes transient increases in
intracellular Ca2+ promoting neuronal migration by acting on
the cytoskeleton protein regulators (Luhmann et al., 2015).
Even if our data showed that perinatal exposure to two doses
of GLA negatively impacts neuroblast homeostasis within the
SVZ-OB system, the present results also show that GLA is able
to induce two different patterns of SVZ alterations suggesting
that several targets might be impacted depending on the dose.
Indeed, cell morphology, considered to be pivotal in the process
of migration (Luskin, 1993; Alvarez-Buylla and Garcia-Verdugo,
2002), is differentially affected by GLA depending on the
dose as illustrated by ex vivo SVZ explants where GLA0.2-
exposed neuroblasts display highly compacted chains whereas
neuroblasts from GLA1-exposed explants seem less altered in
their morphology (although still different from CTL ones). In
support of this, our in vivo BrdU labeling experiments also show
differential effects of GLA depending on the dose. In agreement
with the literature, we observe in CTL offspring that, BrdU+ cells
go out from the SVZ and migrate through the RMS to finally
reach the OB 2 days later. In GLA0.2-exposed animals, BrdU+
neuroblasts are able to migrate from the SVZ to the OB but
our results indicate that changes in SVZ cell proliferation and
defects in migration processes significantly delay the temporal
dynamics of neuroblast migration On the contrary, no alteration
of proliferation is observed in GLA1-exposed offspring in vivo
while many cells, despite being able to leave the SVZ as well as
CTL ones, are found in an abnormal ectopic location, the caudate
putamen (Cpu), a situation never seen in CTL neuroblasts. These
results are consistent with the SVZ enlargement observed in vivo
and the compacted aspect of chains in SVZ explants, only seen
at the lowest dose. Therefore, it is of importance to notice that,
for some parameters, the doses have the same effect while for
others the effect is qualitatively different. Moreover, we find the
OB in GLA0.2 and GLA1-exposed mice to have an apparently
normal size and structure. This point is relevant because the
number of cells reaching the OB is thought to regulate the size of
the bulbs (Gheusi, 2000). At first glance, the decreased number
of TUNEL+ cells in GLA0.2 and GLA1-exposed mice seem at
odds with the lower increase in BrdU+ cells and the normal
bulb morphology. These data are however in line with previous
study reporting neuronal migration disorders following in utero
exposure to several environmental factors in humans and in
animal models (Wisniewski et al., 1983; Miller, 1986; Gressens
et al., 1992; Shinmura et al., 1997).
Reelin and Cytoskeleton Alterations as the
Cause of GLA-Induced Neurogenesis
Defects
Reelin expression is essential for neuronal migration in the
developing brain, acting as a “detachment signal” of postnatal
neuroblast from the RMS (Simo et al., 2007). In GLA-exposed
mice, the OB expression pattern of reelin seem to be altered
irrespective of the dose. Such findings are in accordance with
our in vivo and ex vivo experiments showing disturbances of
neuroblast migration. The reelin pathway corrects the migration
of early generated interneurons within the olfactory bulb. This
function is a prerequisite for correct OB lamination (Hack
et al., 2002; Hellwig et al., 2012). GLA-induced alterations of the
laminar organization within the OB are clearly consistent with
this. In support of this, reeler mice have been shown to exhibit
ectopic accumulation of neuroblasts in the RMS, failing to transit
from tangential migration in the RMS to radial migration in the
OB (Ayala et al., 2011; Sun et al., 2010). Interestingly, complex
interactions between reeler genotype and early exposure to
environmental toxicants have already been demonstrated, (Keller
and Persico, 2003; Laviola et al., 2006; Persico and Bourgeron,
2006; Mullen et al., 2013).
GLA-induced neurogenesis defects was also reinforced by
observing our transcriptomic analyses on PND15 brains
perinatally exposed to GLA. Indeed, expression pattern of a
series of genes regulating the cytoskeleton, cell proliferation and
cell migration were affected by GLA exposure. Interestingly,
GLA0.2 and GLA1 groups present a different deregulated
pattern, and no dose effect was observed. This result was in
accordance with our ex vivo data showing that a different
cellular morphology observed in explants experiments treated
with GLA0.2 or GLA1. Therefore, GLA0.2 and GLA1 specifically
induced gene deregulation explaining the compacted neuroblasts
chains morphology and abnormal morphology with extension
and branching of the growth cone and abnormally long
dendrites, respectively. However, 11 genes were deregulated in
both GLA0.2 and GLA1 treated groups. Interestingly, these
commonly deregulated genes included pivotal representatives
for the major processes controlling cell migration such as
cytoskeleton rearrangements (Rac, Rho, Rock), cell adhesion
(Arp2/3, Pfn, Actn, Erm), and chemotactic signalization (Rtk,
Itg, Ras) (Khodosevich et al., 2009). ARP complex Arpc3
and Arpc4 which nucleates actin filament growth from the
minus end and allows rapid elongation at the plus end
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FIGURE 6 | Effect of perinatal glufosinate ammonium exposure on the mitral cells in the OB. (A) In the OB, four coronal sections per mice were stained with
Reelin (nearly exclusive expression in mitral cells; red staining) and counterstained with DAPI (nuclear staining; blue staining) [CTL (n = 3), GLA0.2 (n = 3), GLA1 (n =
3)]. (B) The number of mitral cells were determined within the mitral layer. Sections from GLA exposed mice display higher number of mitral cells than CTL. The
number of Reelin+ cells/mm of mitral layer is significantly increased in GLA0.2 and GLA1 mice compared to CTL mice. (C) mRNA expression levels of reelin on whole
brain measured by qPCR. No difference in expression between GLA0.2 (n = 8) and CTL (n = 8), however Reelin is under expressed in GLA1 (n = 8) compared to the
CTL. Each value represents the mean ± SEM (*p < 0.05; **p < 0.01). Scale bar 50 µm. Mi, mitral layer; Grl, granular layer; Gl, Glomerular layer.
(Alberts et al., 2002), PFN (Pfn1 and Fscn1) promoting actin
migration/proliferation of non-muscle cells (Wang et al., 2014),
MLC (My19) regulating cytoskeleton contraction (Saban et al.,
2006), GF (FgF1) regulating cytoskeletal organization collagen
contraction (Ding et al., 2000), GPCR/Chemokine (Chrm4
and CCl3) regulating chemotaxis cell migration and actin
cytoskeleton moving machinery (Yang et al., 2012), and Ras/Rac
system (Arhgdib) which controls the assembly and disassembly
of the actin cytoskeleton in response to extracellular signals
(Ory et al., 2000). RhoGTPase family is one of the major
regulators of cytoskeletal properties and plays essential functions
in cerebral cortex development. These functions are known to
be highly associated with glutamate homeostasis to regulate
neuroblast proliferation and migration (Di Giorgi-Gerevini
et al., 2005; Platel et al., 2008). Here we show, that perinatal
organophosphate GLA exposure affect cell migration modulating
not only Reelin activity, but also a series of other genes involved
in cytoskeleton regulation, thus potentially contributing to the
neurodevelopmental basis of autism-like behavior.
On The Unusual “Dose-Dependent” Effects
of Perinatal Exposure to GLA
Most of the results presented here indicate that perinatal
exposure to GLA may have different effects depending on the
dose to which individuals are exposed. In support of this, it is
of interest to see that the lowest dose seems to be more harmful
in regards of some parameters we studied here. Such results
clearly challenge the prevailing dogma that “the dose makes the
poison” as the reported effects show a qualitatively different dose-
dependent response. One explanation for this could be related to
the structural analogy of GLA to the excitatory neurotransmitter
glutamate. Indeed, GLA may have a glutamate-like effect at low
dosage whereas, at higher dosage, it may induce detrimental
effects on neurons irrespective of its signaling to glutamate
receptors. For instance, one can assume that, at high dosage, GLA
may be added to α/β tubulin heterodimers instead of glutamate
and consequently have disturbing effects on polyglutamylation
processes. Some experiments are currently in progress in order
to test such a hypothesis.
For a number of years now, there have been reports showing
that environmental toxicants can have effects at low dosage and
that these cannot be predicted and extrapolated from effects at
higher doses (Vandenberg et al., 2012). The present data strongly
suggest that GLA is likely to be one of these toxicant. Our
previous study (Laugeray et al., 2014) considerably strengthens
this assumption as some neurodevelopmental outputs were
commonly affected by the two doses of GLA while for
others, it was not the case. This was especially true for
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FIGURE 7 | Signaling pathways involving the cytoskeleton remodeling. Here we show proteins whose expression is deregulated in GLA0.2- (A) and
GLA1-exposed pups (B). Significant number of deregulated genes after perinatal exposure to GLA, involved in cell migration and cytoskeleton dynamics can cause
problems at cellular levels of migration and adhesion and even vesicular transport in the cell. Figure from David Software database and adapted by S. Mortaud.
Differentially regulated cytoskeleton genes were determined using a one-way ANOVA analysis and a Benjamini Hochberg False Discovery Rate (FDR) (<0.05) method
for multiple comparison corrections.
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TABLE 1 | Cytoskeleton-deregulated genes after perinatal GLA exposure.
Transcripts
Cluster Id
FC ([GLA0.2]
vs. [CTL])
Log FC ([GLA0.2]
vs. [CTL])
FC ([GLA1]
vs. [CTL])
Log FC ([GLA1]
vs. [CTL])
Gene Description Gene Symbol
6839743 –1.20 –0.27 1.06 0.09 v-crk sarcoma virus CT10 oncogene homolog
(avian)-like
Crkl
6970635 –1.20 –0.27 –1.01 –0.02 Related RAS viral (r-ras) oncogene homolog 2 Rras2
6791641 –1.62 –0.70 1.10 0.14 Glial fibrillary acidic protein Gfap
6905321 –1.59 –0.66 1.10 0.14 Profilin 2 Pfn2
6964244 –1.45 –0.54 1.11 0.15 Mitogen-activated protein kinase 3 Mapk3
6942751 –1.44 –0.52 –1.18 –0.23 Guanine nucleotide binding protein, alpha 12 Gna12
6771558 –1.43 –0.51 1.13 0.17 Dynactin 2 Dctn2
6819974 –1.42 –0.51 –1.07 –0.10 Neurofilament, light polypeptide Nefl
6787176 –1.42 –0.50 1.01 0.02 nucleophosmin 1 Npm1
6985399 –1.41 –0.50 1.13 0.18 Breast cancer anti-estrogen resistance 1 Bcar1
6942654 –1.40 –0.48 –1.13 –0.18 Platelet derived growth factor, alpha Pdgfa
6970139 –1.38 –0.47 1.05 0.07 ADP-ribosylation factor interacting protein 2 Arfip2
6871078 –1.35 –0.43 1.13 0.17 Kinesin light chain 2 Klc2
6929817 –1.35 –0.43 –1.11 –0.15 Fibroblast growth factor receptor 3 Fgfr3
6795784 –1.33 –0.41 –1.04 –0.05 ADP-ribosylation factor 6 | predicted gene 9887 Arf6|Gm9887
6941780 –1.33 –0.41 1.04 0.06 Ras homolog gene family, member f |
transmembrane protein 120B
Rhof|Tmem120b
6789344 –1.33 –0.41 –1.07 –0.10 Fibroblast growth factor 11 | sperm maturation 1 Fgf11|Spem1
6804486 –1.32 –0.41 –1.07 –0.10 Guanosine diphosphate (GDP) dissociation
inhibitor 2
Gdi2
6837144 –1.30 –0.38 –1.06 –0.08 Platelet derived growth factor, B polypeptide Pdgfb
6850749 –1.30 –0.37 1.15 0.20 Tubulin-specific chaperone C Tbcc
6876380 –1.29 –0.37 –1.01 –0.01 Gelsolin Gsn
6870125 –1.29 –0.37 –1.02 –0.03 Internexin neuronal intermediate filament protein,
alpha | 5’-nucleotidase, cytosolic II
Ina|Nt5c2
6918036 –1.29 –0.37 1.11 0.16 Capping protein (actin filament) muscle Z-line, beta Capzb
6838136 –1.27 –0.34 –1.04 –0.06 Twinfilin, actin-binding protein, homolog 1
(Drosophila)
Twf1
6965786 –1.27 –0.34 1.01 0.01 MAP/microtubule affinity-regulating kinase 4 Mark4
6848568 –1.27 –0.34 1.09 0.12 Ezrin Ezr
6782572 –1.26 –0.34 –1.04 –0.05 G protein-coupled receptor kinase-interactor 1 Git1
6984416 –1.26 –0.33 1.16 0.21 Nudix (nucleoside diphosphate linked moiety
X)-type motif 21
Nudt21
6838392 –1.25 –0.32 1.13 0.17 Rho family GTPase 1 Rnd1
6791204 –1.25 –0.32 –1.05 –0.07 SRC kinase signaling inhibitor 1 Srcin1
6784244 –1.25 –0.32 1.15 0.20 Tubulin, gamma 1 | tubulin, gamma 2 Tubg1|Tubg2
6790585 –1.24 –0.31 1.04 0.05 Dynein light chain LC8-type 2 Dynll2
6942909 –1.24 –0.31 –1.13 –0.17 RAS-related C3 botulinum substrate 1 |
diacylglycerol lipase, beta
Rac1|Daglb
6959452 –1.23 –0.30 –1.09 –0.12 Sirtuin 2 (silent mating type information regulation 2,
homolog) 2 (S. cerevisiae)
Sirt2
6781456 –1.22 –0.29 –1.07 –0.10 Lethal giant larvae homolog 1 (Drosophila) Llgl1
6843886 –1.22 –0.29 1.04 0.06 Nucleotide binding protein 1 | family with sequence
similarity 18, member A
Nubp1|Fam18a
6881787 –1.22 –0.29 –1.03 –0.04 Destrin Dstn
6774794 –1.21 –0.28 1.13 0.17 Cyclin-dependent kinase 1 Cdk1
6942379 –1.21 –0.27 1.05 0.07 LIM-domain containing, protein kinase Limk1
6933073 1.21 0.27 –1.16 –0.22 Polycystic kidney disease 2 Pkd2
6897556 1.21 0.27 –1.08 –0.11 Transient receptor potential cation channel,
subfamily C, member 4
Trpc4
6899092 1.21 0.28 1.00 0.01 IQ motif containing GTPase activating protein 3 Iqgap3
6811117 1.22 0.28 1.03 0.04 Tubulin-specific chaperone E Tbce
(Continued)
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TABLE 1 | Continued
Transcripts
Cluster Id
FC ([GLA0.2]
vs. [CTL])
Log FC ([GLA0.2]
vs. [CTL])
FC ([GLA1]
vs. [CTL])
Log FC ([GLA1]
vs. [CTL])
Gene Description Gene Symbol
7013165 1.24 0.31 1.20 0.26 Fibroblast growth factor 16 Fgf16
6877080 1.26 0.33 –1.19 –0.25 Rap1 interacting factor 1 homolog (yeast) | nebulin Rif1|Neb
6919300 1.27 0.34 1.03 0.04 Moloney sarcoma oncogene Mos
7019970 1.28 0.36 –1.19 –0.25 Doublecortin Dcx
6783259 1.29 0.36 1.08 0.11 Tubulin, delta 1 Tubd1
7011964 1.35 0.43 1.03 0.04 Arginine vasopressin receptor 2 | Rho GTPase
activating protein 4
Avpr2|Arhgap4
6778528 –1.20 –0.27 1.28 0.36 YKT6 homolog (S. cerevisiae) Ykt6
6949084 –1.21 –0.28 1.44 0.52 Actin related protein 2/3 complex, subunit 4 Arpc4
6790294 –1.23 –0.30 1.32 0.40 Chemokine (C-C motif) ligand 3 Ccl3
6934130 –1.23 –0.30 1.38 0.46 Actin related protein 2/3 complex, subunit 3 Arpc3
6882627 –1.26 –0.34 1.48 0.56 Myosin, light polypeptide 9, regulatory Myl9
6879087 –1.29 –0.36 1.20 0.27 Cholinergic receptor, muscarinic 4 Chrm4
6935370 –1.29 –0.37 –1.20 –0.26 Fascin homolog 1, actin bundling protein
(Strongylocentrotus purpuratus)
Fscn1
6894640 –1.30 –0.38 1.36 0.44 Myosin, light polypeptide 9, regulatory Myl9
6789444 –1.31 –0.39 1.39 0.47 Profilin 1 Pfn1
6957763 –1.34 –0.43 1.45 0.53 Rho, GDP dissociation inhibitor (GDI) beta Arhgdib
6864837 –1.53 –0.62 1.25 0.32 fibroblast growth factor 1 Fgf1
6969916 –1.00 0.00 –1.20 –0.26 Nuclear mitotic apparatus protein 1 Numa1
6884986 1.00 0.00 –1.24 –0.31 Nebulette Nebl
6748525 1.06 0.08 –1.57 –0.65 Dystonin | RIKEN cDNA D630036G22 gene Dst|D630036G
22Rik
6928487 1.06 0.09 –1.42 –0.50 A kinase (PRKA) anchor protein (yotiao) 9 Akap9
6859935 1.13 0.17 –1.40 –0.49 Adenomatosis polyposis coli Apc
6928889 1.14 0.18 –1.40 –0.48 Piccolo (presynaptic cytomatrix protein) Pclo
6768609 1.02 0.03 –1.39 –0.47 Ankyrin 3, epithelial Ank3
6872616 1.13 0.18 –1.39 –0.47 Protein kinase, cGMP-dependent, type I Prkg1
6886244 1.16 0.21 –1.38 –0.47 Low density lipoprotein-related protein 1B (deleted
in tumors) | RAN, member RAS oncogene family
Lrp1b|Ran
7012305 1.17 0.23 –1.37 –0.45 Dystrophin, muscular dystrophy Dmd
6981190 –1.02 –0.02 –1.34 –0.43 Hook homolog 3 (Drosophila) Hook3
6759621 –1.11 –0.15 –1.33 –0.41 Fibronectin 1 Fn1
6781941 –1.03 –0.05 –1.33 –0.41 Myosin, heavy polypeptide 10, non-muscle Myh10
6804898 1.17 0.23 –1.33 –0.41 Lysosomal trafficking regulator Lyst
6801500 1.16 0.21 –1.32 –0.40 Ninein Nin
6787743 –1.05 –0.08 –1.31 –0.39 Cytoplasmic FMR1 interacting protein 2 Cyfip2
6903711 1.04 0.05 –1.31 –0.38 Neuroligin 1 Nlgn1
6863301 1.15 0.20 –1.30 –0.38 Rho-associated coiled-coil containing protein kinase
1
Rock1
6828492 1.19 0.25 –1.29 –0.37 RPTOR independent companion of MTOR, complex
2
Rictor
6947558 1.17 0.22 –1.29 –0.37 Alstrom syndrome 1 homolog (human) Alms1
6941813 –1.09 –0.12 –1.27 –0.35 CAP-GLY domain containing linker protein 1 |
hypothetical protein LOC100503214
Clip1|LOC1005
03214
6868728 –1.10 –0.14 –1.27 –0.34 Amyloid beta (A4) precursor protein binding, family
A, member 1
Apba1
6782776 1,12 0.16 –1.26 –0.33 Neurofibromatosis 1 Nf1
6975861 1.12 0.17 –1.26 –0.33 Sorbin and SH3 domain containing 2 | RIKEN cDNA
D330022K07 gene | hypothetical LOC100503324
Sorbs2|D330022
K07Rik|LOC
100503324
6994954 –1.07 –0.10 –1.25 –0.32 Rho guanine nucleotide exchange factor (GEF) 12 Arhgef12
6836973 –1.08 –0.12 –1.25 –0.32 Myosin, heavy polypeptide 9, non-muscle Myh9
(Continued)
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TABLE 1 | Continued
Transcripts
Cluster Id
FC ([GLA0.2]
vs. [CTL])
Log FC ([GLA0.2]
vs. [CTL])
FC ([GLA1]
vs. [CTL])
Log FC ([GLA1]
vs. [CTL])
Gene Description Gene Symbol
6975701 1.06 0.08 –1.25 –0.32 Pericentriolar material 1 Pcm1
6969903 –1.02 –0.03 –1.23 –0.30 Nuclear mitotic apparatus protein 1 Numa1
6951276 1.06 0.08 –1.22 –0.29 Bicaudal D homolog 1 (Drosophila) Bicd1
6875722 –1.17 –0.22 –1.22 –0.29 ATP-binding cassette, sub-family A (ABC1),
member 2
Abca2
6795451 1.09 0.13 –1.22 –0.29 Pinin Pnn
6857810 1.04 0.05 –1.21 –0.27 Leucine-rich PPR-motif containing Lrpprc
6796380 1.20 0.26 –1.20 –0.27 actinin, alpha 1 | striamin Actn1|Strm
6758995 1.07 0.10 –1.20 –0.27 Amyotrophic lateral sclerosis 2 (juvenile) homolog
(human) | membrane protein, palmitoylated 4
(MAGUK p55 subfamily member 4)
Als2|Mpp4
6876154 –1.05 –0.06 –1.20 –0.26 c-abl oncogene 1, non-receptor tyrosine kinase Abl1
6916557 –1.01 –0.01 1.21 0.27 IAP promoted placental gene | transmembrane
protein 69
Ipp|Tmem69
6839552 –1.19 –0.25 1.21 0.28 Nuclear distribution gene E homolog 1 (A nidulans) Nde1
6887836 –1.03 –0.04 1.21 0.28 WAS/WASL interacting protein family, member 1 Wipf1
6880587 –1.17 –0.23 1.21 0.28 HAUS augmin-like complex, subunit 2 Haus2
6843088 1.12 0.16 1.21 0.28 Superoxide dismutase 1, soluble Sod1
6946800 1.11 0.15 1.21 0.28 Superoxide dismutase 1, soluble Sod1
6986677 –1.16 –0.22 1.22 0.28 Platelet-derived growth factor, D polypeptide Pdgfd
6776507 1.09 0.13 1.23 0.30 RIKEN cDNA 4930430F08 gene | centrosomal
protein 290
4930430F08Rik|
Cep290
6858126 –1.03 –0.05 1.23 0.30 Karyopherin (importin) alpha 2 Kpna2
6769179 –1.19 –0.25 1.24 0.31 Calponin 2 Cnn2
7015993 1.11 0.16 1.24 0.32 ubiquitously expressed transcript Uxt
6899767 –1.05 –0.08 1.25 0.32 Integrin, alpha 10 | peroxisomal biogenesis factor 11
beta
Itga10|Pex11b
6835329 1.13 0.18 1.26 0.33 Actin-binding Rho activating protein Abra
6864748 1.06 0.08 1.26 0.33 Ubiquitously expressed transcript Uxt
6988603 –1.14 –0.18 1.26 0.34 Thymus cell antigen 1, theta Thy1
6998165 –1.14 –0.19 1.27 0.35 Mitochondrial ribosomal protein S22 | capping
protein (actin filament) muscle Z-line, alpha 1
Mrps22|Capza1
6960328 –1.19 –0.25 1.27 0.35 Harvey rat sarcoma oncogene, subgroup R Rras
6839334 –1.13 –0.18 1.28 0.36 Nucleotide binding protein 1 Nubp1
6792994 –1.04 –0.06 1.29 0.36 Profilin family, member 4 Pfn4
7017603 1.00 0.01 1.29 0.36 N(alpha)-acetyltransferase 10, NatA catalytic
subunitNalpha acetyltransferase 10 | Rho GTPase
activating protein 4
Naa10|Arhgap4
6996448 –1.07 –0.09 1.29 0.37 tropomyosin 1, alpha Tpm1
6921068 –1.08 –0.11 1.32 0.40 Dynactin 3 | AT rich interactive domain 3C
(BRIGHT-like)
Dctn3|Arid3c
6785483 –1.17 –0.22 1.32 0.40 RAS-related C3 botulinum substrate 3 Rac3
6818956 –1.15 –0.21 1.33 0.42 Ribonuclease, RNase A family 4 | angiogenin,
ribonuclease, RNase A family, 5
Rnase4|Ang
6784526 1.06 0.08 1.35 0.43 Myosin, light polypeptide 4 | lin-52 homolog (C.
elegans) | predicted gene 7020
Myl4|Lin52|
Gm7020
6934584 –1.08 –0.11 1.40 0.48 RAN, member RAS oncogene family Ran
6817978 –1.05 –0.07 1.42 0.51 Troponin C, cardiac/slow skeletal Tnnc1
FC: Fold Change; Red: Upregulated genes; Blue: downregulated genes.
anatomical abnormalities indicating macrocephaly at 1 mg/kg
and microcephaly at 0.2 mg/kg. Interestingly, such changes were
concomitant with reduced Pten mRNA levels in the brain of
GLA1-exposed pups matching the macrocephaly in the same
mice, but perinatal exposure to the lower dose had the opposite
effect on both Pten expression and brain size (microcephaly).
Such a non-classical “dose dependent” effects were also observed
on bio-behavioral parameters (Laugeray et al., 2014). It is
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therefore essential to build up our knowledge of possible harmful
effects of low-level perinatal exposure to pesticides. This is a
relevant and topical issue as many governmental reports have
noted that early exposure (pre and postnatal) to low or very low
doses of pesticides is not usually covered by the tests required for
regulatory approval, and therefore that it is impossible to estimate
such adverse effects (Bonnefoy, 2012; Watts, 2012).
In summary, our work demonstrates for the first time
the deleterious effect of perinatal exposure to GLA results in
abnormal brain development, both at the cellular and molecular
levels, providing a putative structural explanation for GLA-
induced ASD-like phenotypes in mice. Our data not only identify
the SVZ as a novel target for environmental toxicants, in
particular in case of early exposure to low doses but also pave
the way for unraveling the molecular events that orchestrate the
effect of GLA on cell cytoskeleton.
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Supplementary Figure 1 | Effect of prenatal exposure to GLA on
cyto-architecture of the olfactory bulbs. (A) Schematic of a coronal section of
the olfactory bulb of a mouse brain. (B) Coronal sections in mouse olfactory bulbs
of CTL, GLA0.2, or GLA1 stained with DCX antibody (green) and DAPI (blue), mice
bulbs CTL has a characteristic architecture and many parallel neuroblasts which
migrate to the external layers of the olfactory bulbs; Bulbs from exposed mice
have a different architecture from that of CTL mice, neuroblasts migration no
longer form a parallel architecture. Scale bar 50 µm. NE, neuroepithelium; Mi,
mitral layer; GrL, Granular Layer.
Supplementary Figure 2 | Example of analyzing of arrival of neuroblasts to
the olfactory bulbs by measuring the integrated density. PND5 pups were
injected with BrdU. Coronal sections of the CTL OB were stained with BrdU
(green) and counterstained with DAPI (blue) 2 h (T0+2 h) or 2 days (T0+2 D) after
BrdU injection (top panel). Measurement of the Integrated intensity (RawIntDen)
was performed with imageJ software in three OB sub-structural region
(neuroepithelium:NE; granular layer: GrL; and glomerular layer: Glo). At T0+2 h all
proliferating cells are BrdU+, the labeling is homogeneous in the differents layers
of the olfactory bulbs. At T0+2 D, a large number of BrdU+ cells arrive in the OB.
The measurements of the integrated density showed an increase of signal relative
to the number of BrdU+ cells (bottom panel) showing neuroepithelia (ne)
neuroblasts arrival from rostral stream at T0+2 D. Scale bar: 100 µm. NE,
neuroepithelium; GrL, Granular Layer; Glo, Glomerular layer.
Supplementary Figure 3 | Morphology changing of neuroblast ex vivo
explant culture. Some neuroblasts migrate out of chain. (A) In control, these
neuroblasts have a classical morphology with short cell body, a clear bipolar
morphology and a short and condensed growth cone. (B) In GLA1 exposed
explants, free neuroblasts display abnormal morphology with long dendrite
processes and unstructured growth cone (arrow) displaying extensive branching.
Scale bar: 20 µm.
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